Antigenics Inc. (New York) to Present at UBS Warburg Global Generic and Specialty Pharmaceuticals Conference

NEW YORK--(BUSINESS WIRE)--Antigenics Inc. (NASDAQ: AGEN) today announced that Garo H. Armen, PhD, the company’s chairman and CEO, will present at the UBS Global Generic and Specialty Pharmaceuticals Conference at the Grand Hyatt New York at 9:00 a.m. ET on Wednesday, May 9.

Back to news